Lenalidomide oral MED
Active Awarded Last action
- Contract number
- 36C25726N0241
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $899,347
Award facts
- Contract value 100% obligated
- $899,347.26 Current and potential, with all options
- Completion date 70% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q509 Family & Internal Medicine Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $899,347 |
About this award
This delivery order, awarded February 6, 2026, by Veterans Integrated Service Network 17, provides for the supply of Lenalidomide oral medication to support the Department of Veterans Affairs healthcare system. Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturer and distributor specializing in generic and branded drug products for federal agencies, was selected as the prime contractor. The award carries a ceiling value of $899,347.26 under a firm fixed-price contract structure with no set-aside designation, allowing unrestricted competition among qualified vendors. Performance is scheduled to conclude by February 5, 2027, with all work performed at Exelan's primary facility in Boca Raton.
This delivery order operates under the broader Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which establishes pre-competed pharmaceutical procurement frameworks across federal agencies. Exelan maintains an extensive portfolio of Indefinite Delivery Contracts with the VA National Acquisition Center for critical pharmaceutical products, and this Lenalidomide award represents part of the company's significant ongoing support for VA oncology and hematologic malignancy treatment protocols across multiple Veterans Integrated Service Networks. The award demonstrates Exelan's established capability and strategic role as a long-term federal pharmaceutical supplier serving the VA, Department of Defense, Bureau of Prisons, and Indian Health Service.
Quick answers
Who was awarded contract 36C25726N0241?
36C25726N0241 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on February 6, 2026.
How much is contract 36C25726N0241 worth?
The government has obligated $899,347 on 36C25726N0241.
Is contract 36C25726N0241 an order under another contract?
Yes. 36C25726N0241 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25726N0241 competed?
The extent of competition for 36C25726N0241 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award